# ADC Therapeutics SA (ADCT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ADC Therapeutics SA's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ADCT/mda/fy2025/): filed 2026-03-10; accession 0001628280-26-016491 (https://www.sec.gov/Archives/edgar/data/1771910/000162828026016491/adc-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ADCT/mda/fy2024/): filed 2025-03-27; accession 0001628280-25-015131 (https://www.sec.gov/Archives/edgar/data/1771910/000162828025015131/adc-20241231.htm)
- [FY 2023 MD&A](/company/ADCT/mda/fy2023/): filed 2024-03-13; accession 0001628280-24-010843 (https://www.sec.gov/Archives/edgar/data/1771910/000162828024010843/adc-20231231.htm)

Back to /company/ADCT/